Diffusion-weighted magnetic resonance sequence and CA125/CEA ratio can be used as add-on tools to ultrasound for the differentiation of ovarian from non-ovarian pelvic masses.
<h4>Objective</h4>To provide a straightforward approach to the sequential use of ultrasound (US), magnetic resonance (MR) and serum biomarkers in order to differentiate the origin of pelvic masses, making the most efficient use of these diagnostic resources.<h4>Study design</h4&...
Main Authors: | Patrick Nunes Pereira, Sophie Françoise Derchain, Adriana Yoshida, Ricardo Hoelz de Oliveira Barros, Rodrigo Menezes Jales, Luís Otávio Sarian |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0283212 |
Similar Items
-
Correlation of Molecular Tumor Markers CA125, HE4, and CEA with the Development and Progression of Epithelial Ovarian Cancer
by: Qiuhua Wan, et al.
Published: (2021-06-01) -
Clinical Features and Management of Women with Borderline Ovarian Tumors in a Single Center in Brazil
by: Adriana Yoshida, et al.
Published: (2019-05-01) -
Relationship between Serum Tumor Markers, CA-125, CEA, CA19-9, LDH, and βHCG with Histopathology and Age in Women with Ovarian Tumors
by: Nilajkumar D Bagde, et al.
Published: (2020-12-01) -
CEA, CA125 and CA19-9 levels in congenital gastrointestinal anomalies
by: A Baykal-Erkiliç, et al.
Published: (1999-10-01) -
CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01)